Fortis Wins prestigious BMJ award for successful Antibiotic Review Program
Fortis Mulund, Mumbai, named Medical Team of the Year 2014
Gurgaon, September 26, 2014 - Fortis Healthcare announced today that Fortis Mulund, one of its major hospitals in Mumbai has been conferred
the prestigious British Medical Journal (BMJ) Award for ‘The Medical Team of the Year 2014.’
The honour was bestowed on the hospital for its outstanding “Antibiotic Review Program – and Antibiotic Restriction Policy.”
Rampant
and uncontrolled use of antibiotics has been rendering many of them
progressively ineffective against microbes routinely associated with
hospital infections. The World Health
Organisation (WHO) has now cited this as a major problem and has
declared it a global public health emergency. The WHO has been calling
for judicious antibiotic use and exercising caution in conserving the
world’s armamentarium of known antibiotics.
Congratulating the team at Fortis Mulund, for winning the prestigious BMJ Award,
Mr. Aditya Vij, CEO, Fortis Healthcare Limited, said,
“Antibiotics are a precious weapon in our arsenal against disease. We
need to conserve them through controlled use and pay utmost heed to the
dictum ‘the right drug for the right bug’. With this in
mind, Fortis has instituted a formalised Antimicrobial Stewardship
(AMS) programme at all our hospitals with outstanding results. We are
making significant headway and a definite impact in our hospitals and I
commend the efforts of our Doctors, Nurses and
Pharmacy, in this endeavour.”
The
Antimicrobial Stewardship (AMS) program at Fortis Mulund was set up
more than five years back and has gained significant traction in the
last two years with the rationalisation
in the use of life-saving antibiotics brought about with the
unconditional support of Fortis clinicians, in anti-microbial
prescription practices.
Merck
Sharp and Dohme (MSD), an international pharmaceutical major is
providing valuable know how and guidance in the execution of the
programme.
The
ultimate goal of the program is to educate the community regarding the
misuse of antibiotics and address the global outbreak of anti-microbial
resistance for the safety of our
patients and the larger community.
The program strives for the de-escalation
in the consumption of restricted antibiotics with concomitant benefits
of reduced toxicity,
side effects and costs. The ultimate goal is to address global outbreak
of anti-microbial resistance. The vision is to bring about a change in
the antibiotic prescription pattern amongst clinicians; preserve the
ecology of the hospital with a focus on the
safety of patients and the community.
The
BMJ Awards are UK’s premier medical awards, launched in 2009,
recognising and celebrating the inspirational work done by doctors and
their teams. Organised by The BMJ, one of
the world's leading medical journals, the awards reflect their mission
to improve patient outcomes and showcase the very best healthcare in the
UK.
BMJ Awards India recognize excellence in healthcare in our
country by felicitating individuals, organisations, and initiatives that
demonstrate outstanding and measurable contributions across the
healthcare community.
No comments:
Post a Comment